Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Matrix metalloproteinase-10 is a critical effector of protein kinase Cι-Par6α-mediated lung cancer

Abstract

Protein kinase Cι (PKCι) drives transformed growth of non-small cell lung cancer (NSCLC) cells through the Rho family GTPase Rac1. We show here that PKCι activates Rac1 in NSCLC cells by formation of a PKCι–Par6α complex that drives anchorage-independent growth and invasion through activation of matrix metalloproteinase-10 (MMP-10) expression. RNAi-mediated knockdown of PKCι, Par6α or Rac1 expression inhibits NSCLC transformation and MMP-10 expression in vitro. Expression of wild-type Par6α in Par6α-deficient cells restores transformation and MMP-10 expression, whereas expression of Par6α mutants that either cannot bind PKCι (Par6α-K19A) or couple to Rac1 (Par6α-ΔCRIB) do not. Knockdown of MMP-10 expression blocks anchorage-independent growth and invasion of NSCLC cells and addition of catalytically active MMP-10 to PKCι- or Par6α-deficient cells restores anchorage-independent growth and invasion. Dominant-negative PKCι inhibits tumorigenicity and MMP-10 expression in subcutaneous NSCLC tumors. MMP-10 and PKCι are coordinately overexpressed in primary NSCLC tumors, and tumor MMP-10 expression predicts poor survival in NSCLC patients. Our data define a PKCι–Par6α–Rac1 signaling axis that drives anchorage-independent growth and invasion of NSCLC cells through induction of MMP-10 expression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Bodey B, Bodey Jr B, Groger AM, Siegel SE, Kaiser HE . (2001). Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung. In Vivo 15: 175–180.

    CAS  PubMed  Google Scholar 

  • Cho NH, Hong KP, Hong SH, Kang S, Chung KY, Cho SH . (2004). MMP expression profiling in recurred stage IB lung cancer. Oncogene 23: 845–851.

    Article  CAS  Google Scholar 

  • Delebecq TJ, Porte H, Zerimech F, Copin MC, Gouyer V, Dacquembronne E et al. (2000). Overexpression level of stromelysin 3 is related to the lymph node involvement in non-small cell lung cancer. Clin Cancer Res 6: 1086–1092.

    CAS  PubMed  Google Scholar 

  • Egeblad M, Werb Z . (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161–174.

    Article  CAS  Google Scholar 

  • Erdogan E, Lamark T, Stallings-Mann M, Lee J, Pellecchia M, Thompson EA et al. (2006). Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase Ciota. J Biol Chem 281: 28450–28459.

    Article  CAS  Google Scholar 

  • Fields AP, Regala RP . (2007). Protein kinase C iota: human oncogene, prognostic marker and therapeutic target. Pharmacol Res 55: 487–497.

    Article  CAS  Google Scholar 

  • Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M et al. (2001). Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 98: 13784–13789.

    Article  CAS  Google Scholar 

  • Gill JH, Kirwan IG, Seargent JM, Martin SW, Tijani S, Anikin VA et al. (2004). MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas. Neoplasia 6: 777–785.

    Article  CAS  Google Scholar 

  • Imoto I, Pimkhaokham A, Fukuda Y, Yang ZQ, Shimada Y, Nomura N et al. (2001). SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus. Biochem Biophys Res Commun 286: 559–565.

    Article  CAS  Google Scholar 

  • Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, Larjava H et al. (2004). Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 202: 14–22.

    Article  CAS  Google Scholar 

  • Joberty G, Petersen C, Gao L, Macara IG . (2000). The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat Cell Biol 2: 531–539.

    Article  CAS  Google Scholar 

  • Kleinman HK, Martin GR . (2005). Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15: 378–386.

    Article  CAS  Google Scholar 

  • Kren L, Goncharuk VN, Krenova Z, Stratil D, Hermanova M, Skrickova J et al. (2006). Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies. Cesk Patol 42: 16–19.

    CAS  PubMed  Google Scholar 

  • Mathew R, Khanna R, Kumar R, Mathur M, Shukla NK, Ralhan R . (2002). Stromelysin-2 overexpression in human esophageal squamous cell carcinoma: potential clinical implications. Cancer Detect Prev 26: 222–228.

    Article  CAS  Google Scholar 

  • Muller D, Breathnach R, Engelmann A, Millon R, Bronner G, Flesch H et al. (1991). Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer 48: 550–556.

    Article  CAS  Google Scholar 

  • Noda Y, Takeya R, Ohno S, Naito S, Ito T, Sumimoto H . (2001). Human homologues of the Caenorhabditis elegans cell polarity protein PAR6 as an adaptor that links the small GTPases Rac and Cdc42 to atypical protein kinase C. Genes Cells 6: 107–119.

    Article  CAS  Google Scholar 

  • O-Charoenrat P, Rhys-Evans PH, Eccles SA . (2001). Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127: 813–820.

    CAS  PubMed  Google Scholar 

  • Osada H, Takahashi T . (2002). Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene 21: 7421–7434.

    Article  CAS  Google Scholar 

  • Pimkhaokham A, Shimada Y, Fukuda Y, Kurihara N, Imoto I, Yang ZQ et al. (2000). Nonrandom chromosomal imbalances in esophageal squamous cell carcinoma cell lines: possible involvement of the ATF3 and CENPF genes in the 1q32 amplicon. Jpn J Cancer Res 91: 1126–1133.

    Article  CAS  Google Scholar 

  • Qiu RG, Abo A, Steven Martin G . (2000). A human homolog of the C. elegans polarity determinant Par-6 links Rac and Cdc42 to PKCzeta signaling and cell transformation. Curr Biol 10: 697–707.

    Article  CAS  Google Scholar 

  • Regala RP, Weems C, Jamieson L, Copland JA, Thompson EA, Fields AP . (2005a). Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity. J Biol Chem 280: 31109–31115.

    Article  CAS  Google Scholar 

  • Regala RP, Weems C, Jamieson L, Khoor A, Edell ES, Lohse CM et al. (2005b). Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer Res 65: 8905–8911.

    Article  CAS  Google Scholar 

  • Snaddon J, Parkinson EK, Craft JA, Bartholomew C, Fulton R . (2001). Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus. Br J Cancer 84: 1630–1634.

    Article  CAS  Google Scholar 

  • Stallings-Mann M, Jamieson L, Regala RP, Weems C, Murray NR, Fields AP . (2006). A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells. Cancer Res 66: 1767–1774.

    Article  CAS  Google Scholar 

  • Van Themsche C, Alain T, Kossakowska AE, Urbanski S, Potworowski EF, St-Pierre Y . (2004). Stromelysin-2 (matrix metalloproteinase 10) is inducible in lymphoma cells and accelerates the growth of lymphoid tumors in vivo. J Immunol 173: 3605–3611.

    Article  CAS  Google Scholar 

  • Zhang J, Anastasiadis PZ, Liu Y, Thompson EA, Fields AP . (2004). Protein kinase C βII induces cell invasion through a Ras/MEK−, PKCiota/RAC 1-dependent signaling pathway. J Biol Chem 279: 22118–22123.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge Dr Evette Radisky for recombinant human MMP-3 enzyme and expertise in protease activity assays; Dr Eric Edell, Aaron Bungum, Capella Weems and Ying Zhang for assistance in acquisition, processing and analysis of human lung cancer tissue samples; Jennifer Havens and the Mayo Clinic RNA Interference Technology Resource for RNAi reagents and Pam Kreinest and Brandy Edenfield for immunohistochemistry analysis. This work was supported in part through grants from the National Institutes of Health (CA081436) and a Team Science Project grant from the James and Esther King Biomedical Research Program to APF.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A P Fields.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frederick, L., Matthews, J., Jamieson, L. et al. Matrix metalloproteinase-10 is a critical effector of protein kinase Cι-Par6α-mediated lung cancer. Oncogene 27, 4841–4853 (2008). https://doi.org/10.1038/onc.2008.119

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2008.119

Keywords

This article is cited by

Search

Quick links